What does Biofrontera Inc. do?

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are…

What is Biofrontera Inc.'s P/E and P/B ratio?

Biofrontera Inc. has a P/E ratio of -1.8 and a P/B ratio of 1.95.

What is Biofrontera Inc.'s debt-to-equity ratio?

Biofrontera Inc. has a debt-to-equity ratio of 1.26.

How much does Biofrontera Inc. owe compared with what it owns?

Biofrontera Inc. owes $0.75 for every $1 it owns (balance sheet Jun 2026), which is moderate.

Does Biofrontera Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. Biofrontera Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 07 Jan 2026). It has no yellow flags.

Where can I read the latest news about Biofrontera Inc.?

Recent headlines about Biofrontera Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Biofrontera Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Biofrontera Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

Biofrontera Inc.

Q: What is Biofrontera Inc.'s Positivity rank?

Biofrontera Inc. is ranked #5,212 of 6,774 companies globally and #2,794 of 4,000 in United States on PositoAI, with a Positivity Score of 18,092.

NasdaqCM: BFRI · Healthcare

Positivity Index

#5,212 / 6,774

Global

#2,794 / 4,000

United States

Positivity Score

18,092

Rank→

PosiRed: 1 active red flag (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 07 Jan 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

Biofrontera Inc. — Overview & Financial Snapshot

Biofrontera Inc. (NasdaqCM: BFRI) is a Healthcare company, ranked #5,212 of 6,774 companies globally and #2,794 of 4,000 in United States on PositoAI, with a Positivity Score of 18,092. Its market capitalisation is ₹109.49 Cr ($11.60M), P/E ratio is -1.8 and P/B ratio is 1.95. It currently has 1 active red flag (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →